Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Nov:28 Suppl 2:2500-2508.
doi: 10.1111/odi.14086. Epub 2021 Dec 11.

Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial

Affiliations
Randomized Controlled Trial

Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial

Denis Damião Costa et al. Oral Dis. 2022 Nov.

Abstract

Objectives: This study aimed to evaluate the effect of 0.12% chlorhexidine gluconate on the salivary load of SARS-CoV-2.

Materials and methods: A randomized, double-blind, placebo-controlled trial was performed on 100 participants positive for SARS-CoV-2. In the test group (n = 50), volunteers gargled with a mouthwash containing 15 ml of 0.12% chlorhexidine gluconate for 1 min, while the control group (n = 50) used a placebo. Saliva samples were obtained before (baseline) and 5 and 60 min after using the solutions. Real-time reverse transcription polymerase chain reaction assays (qRT-PCR) were carried out and the cycle threshold (Ct) was computed. The chi-square test and t-test were used for group comparison (p ≤ 0.05).

Results: The differences in Ct values between the 5-min evaluation and baseline (test group: 2.19 ± 4.30; control: -0.40 ± 3.87, p = 0.002) and between 60 min and baseline (test group: 2.45 ± 3.88; control: 0.76 ± 4.41, p = 0.05) were significantly greater in the test group, revealing a reduction of viral load. Furthermore, there was a reduction in the load of SARS-CoV-2 in 72% of the volunteers using chlorhexidine versus 30% in the control group (p = 0.001).

Conclusions: Chlorhexidine gluconate (0.12%) was effective in reducing salivary SARS-CoV-2 load for at least 60 min.

Keywords: COVID-19; clinical trial; infection control; mouthwash; pandemic; viral load.

PubMed Disclaimer

References

REFERENCES

    1. Addy, M., Jenkins, S., & Newcombe, R. (1991). The effect of some chlorhexidine-containing mouthrinses on salivary bacterial counts. Journal of Clinical Periodontology, 18(2), 90-93. https://doi.org/10.1111/j.1600-051x.1991.tb01694.x
    1. Bidra, A. S., Pelletier, J. S., Westover, J. B., Frank, S., Brown, S. M., & Tessema, B. (2020). Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists, 29(7), 599-603. https://doi.org/10.1111/jopr.13220
    1. Blumenthal, D., Causino, N., Chang, Y. C., Culpepper, L., Marder, W., Saglam, D., Stafford, R., & Starfield, B. (1999). The duration of ambulatory visits to physicians. The Journal of Family Practice, 48(4), 264-271.
    1. Burton, M. J., Clarkson, J. E., Goulao, B., Glenny, A.-M., McBain, A. J., Schilder, A. G. M., Webster, K. E., & Worthington, H. V. (2020). Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them. The Cochrane Database of Systematic Reviews, 9(9), CD013627. https://doi.org/10.1002/14651858.CD013627.pub2
    1. Centers for Disease Control and Prevention - CDC. (2020). Guidance for dental settings: interim infection prevention and control guidance for dental settings during the coronavirus disease 2019 (COVID-19) pandemic; [Accessed 2021 Jan 02]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/dental-settings.html

Publication types

LinkOut - more resources